BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 20224070)

  • 21. The effect of phosphatidylinositol-3 kinase inhibition on matrix metalloproteinase-9 and reactive oxygen species release from chronic obstructive pulmonary disease neutrophils.
    Gupta V; Khan A; Higham A; Lemon J; Sriskantharajah S; Amour A; Hessel EM; Southworth T; Singh D
    Int Immunopharmacol; 2016 Jun; 35():155-162. PubMed ID: 27049289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histone deacetylase-2 and airway disease.
    Barnes PJ
    Ther Adv Respir Dis; 2009 Oct; 3(5):235-43. PubMed ID: 19812111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cathelicidin LL-37 restoring glucocorticoid function in smoking and lipopolysaccharide-induced airway inflammation in rats.
    Weng JZ; Wang Y; Sun TY
    Chin Med J (Engl); 2019 Mar; 132(5):569-576. PubMed ID: 30741829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting the epigenome in the treatment of asthma and chronic obstructive pulmonary disease.
    Barnes PJ
    Proc Am Thorac Soc; 2009 Dec; 6(8):693-6. PubMed ID: 20008877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease.
    Barnes PJ
    J Allergy Clin Immunol; 2013 Mar; 131(3):636-45. PubMed ID: 23360759
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Corticosteroid resistance in chronic obstructive pulmonary disease: inactivation of histone deacetylase.
    Barnes PJ; Ito K; Adcock IM
    Lancet; 2004 Feb; 363(9410):731-3. PubMed ID: 15001333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identifying Molecular Targets for New Drug Development for Chronic Obstructive Pulmonary Disease: What Does the Future Hold?
    Barnes PJ
    Semin Respir Crit Care Med; 2015 Aug; 36(4):508-22. PubMed ID: 26238638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Denitrosylation of HDAC2 by targeting Nrf2 restores glucocorticosteroid sensitivity in macrophages from COPD patients.
    Malhotra D; Thimmulappa RK; Mercado N; Ito K; Kombairaju P; Kumar S; Ma J; Feller-Kopman D; Wise R; Barnes P; Biswal S
    J Clin Invest; 2011 Nov; 121(11):4289-302. PubMed ID: 22005302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Curcumin modulates the effect of histone modification on the expression of chemokines by type II alveolar epithelial cells in a rat COPD model.
    Gan L; Li C; Wang J; Guo X
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2765-2773. PubMed ID: 27853364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A role for phosphoinositol 3-kinase delta in the impairment of glucocorticoid responsiveness in patients with chronic obstructive pulmonary disease.
    Marwick JA; Caramori G; Casolari P; Mazzoni F; Kirkham PA; Adcock IM; Chung KF; Papi A
    J Allergy Clin Immunol; 2010 May; 125(5):1146-53. PubMed ID: 20381852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-malarial drug artesunate protects against cigarette smoke-induced lung injury in mice.
    Ng DS; Liao W; Tan WS; Chan TK; Loh XY; Wong WS
    Phytomedicine; 2014 Oct; 21(12):1638-44. PubMed ID: 25442271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Erythromycin reverses cigarette smoke extract-induced corticosteroid insensitivity by inhibition of the JNK/c-Jun pathway.
    Bin YF; Ma N; Lu YX; Sun XJ; Liang Y; Bai J; Zhang JQ; Li MH; Zhong XN; He ZY
    Free Radic Biol Med; 2020 May; 152():494-503. PubMed ID: 31770582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carbocysteine restores steroid sensitivity by targeting histone deacetylase 2 in a thiol/GSH-dependent manner.
    Song Y; Lu HZ; Xu JR; Wang XL; Zhou W; Hou LN; Zhu L; Yu ZH; Chen HZ; Cui YY
    Pharmacol Res; 2015 Jan; 91():88-98. PubMed ID: 25500537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term treatment with theophylline reduces neutrophils, interleukin-8 and tumor necrosis factor-alpha in the sputum of patients with chronic obstructive pulmonary disease.
    Iiboshi H; Ashitani J; Katoh S; Sano A; Matsumoto N; Mukae H; Nakazato M
    Pulm Pharmacol Ther; 2007; 20(1):46-51. PubMed ID: 16413994
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Theophylline.
    Barnes PJ
    Am J Respir Crit Care Med; 2013 Oct; 188(8):901-6. PubMed ID: 23672674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resveratrol impairs the release of steroid-resistant inflammatory cytokines from human airway smooth muscle cells in chronic obstructive pulmonary disease.
    Knobloch J; Sibbing B; Jungck D; Lin Y; Urban K; Stoelben E; Strauch J; Koch A
    J Pharmacol Exp Ther; 2010 Dec; 335(3):788-98. PubMed ID: 20801891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A mucoactive drug carbocisteine ameliorates steroid resistance in rat COPD model.
    Song Y; Yu P; Lu JJ; Lu HZ; Zhu L; Yu ZH; Chen HZ; Cui YY
    Pulm Pharmacol Ther; 2016 Aug; 39():38-47. PubMed ID: 27328977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Restoration of HDAC2 and Nrf2 by andrographolide overcomes corticosteroid resistance in chronic obstructive pulmonary disease.
    Liao W; Lim AYH; Tan WSD; Abisheganaden J; Wong WSF
    Br J Pharmacol; 2020 Aug; 177(16):3662-3673. PubMed ID: 32335896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Xanthines and Phosphodiesterase Inhibitors.
    Spina D; Page CP
    Handb Exp Pharmacol; 2017; 237():63-91. PubMed ID: 27844172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Baicalin is anti-inflammatory in cigarette smoke-induced inflammatory models in vivo and in vitro: A possible role for HDAC2 activity.
    Li L; Bao H; Wu J; Duan X; Liu B; Sun J; Gong W; Lv Y; Zhang H; Luo Q; Wu X; Dong J
    Int Immunopharmacol; 2012 May; 13(1):15-22. PubMed ID: 22421405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.